Introduction/Overview
Alpinein (CAS number: 36052-37-6) is a natural flavonoid compound mainly isolated from ginger plants such as Alpinia katsumadai. As a member of the flavonoid family, mountain ginger extract has attracted widespread attention for its diverse biological activities, especially demonstrating significant pharmacological potential in antibacterial, anti-inflammatory, anti-tumor, and multi organ protection. In recent years, with the in-depth study of the pharmacological mechanisms of natural products, the application prospects of mountain ginger extract in various pathological states such as cardiovascular disease, liver injury, and neurodegenerative diseases have gradually become clear. This article will provide a systematic review of the chemical structure and physicochemical properties, plant sources, and extraction methods of mountain ginger extract. The focus will be on analyzing its pharmacological activity and molecular mechanisms, exploring its medicinal properties and pharmacokinetic characteristics, and finally looking forward to its clinical application potential and future research directions.
Chemical structure and physicochemical properties
The chemical formula of mountain ginger extract is C16H14O4, with a molecular weight of 270.28, belonging to the ether structure of flavonoids. Its basic skeleton is a flavonoid core with methoxy substituents, which endows it with good lipid solubility and stability. In terms of physical and chemical properties, the LogP value of mountain ginger extract is about 2.4, indicating moderate lipid solubility, which is beneficial for cell membrane penetration and bioavailability. Its topological polar surface area (TPSA) is 55.76, and the number of hydrogen bond acceptors is 4, indicating that it has a certain hydrophilicity in intermolecular forces, balancing the characteristics of lipophilicity and hydrophilicity. The high permeability of the blood-brain barrier suggests its potential application value in central nervous system diseases. Toxicological evaluation shows that mountain ginger extract has no significant hepatotoxicity, cardiotoxicity, or hERG channel inhibition effect, and the Ames mutagenicity test is negative, indicating high safety.
Plant sources and extraction methods
Shanjiangsu mainly comes from the ginger plant Alpinia katsumadai, and has also been reported in other Alpinia plants. As a traditional Chinese medicinal herb, cardamom is widely used in the treatment of digestive system diseases, and its active ingredient, gingerol, is rich in content. The extraction method usually uses organic solvent extraction combined with column chromatography separation technology. The specific process includes: crushing dried cardamom, reflux extraction with ethanol or methanol as solvents, concentration, separation by silica gel column chromatography, purification by high performance liquid chromatography (HPLC), and finally obtaining high-purity mountain ginger extract. In recent years, emerging technologies such as ultrasound assisted extraction and microwave-assisted extraction have also been applied to improve extraction efficiency and purity. In addition, researchers have attempted to use methods such as counter current chromatography to achieve efficient separation of mountain ginger extract based on its structural characteristics.
Pharmacological activity research
Antibacterial and antiviral activity
Shan Jiang Su exhibits broad-spectrum antibacterial activity and can inhibit the growth of various Gram positive and Gram negative bacteria. Its antibacterial mechanism mainly involves disrupting the integrity of bacterial cell membranes and interfering with cellular metabolic processes. The inhibitory effect on viral infection has also been reported, especially in respiratory virus models, where resveratrol can exert its effects by regulating host immune response and directly inhibiting virus replication.
anti-inflammatory effect
Shanjiangsu has shown significant anti-inflammatory activity in various inflammatory models. Its mechanism involves inhibiting the production of inflammatory mediators such as tumor necrosis factor - α (TNF - α), interleukin-6 (IL-6), and nitric oxide (NO). Shanjiangsu can inhibit the inflammatory response induced by lipopolysaccharide (LPS), activate the peroxisome proliferator activated receptor - γ (PPAR - γ) and nuclear factor E2 related factor 2 (Nrf2) signaling pathways, and downregulate the expression of Toll like receptor 4 (TLR4), thereby reducing the release of inflammatory mediators and tissue damage.
Antitumor activity
The anti-tumor effect of mountain ginger extract has been validated in various cancer cell lines. It mainly works by inhibiting tumor cell proliferation, promoting cell apoptosis, and inhibiting metastasis. The molecular mechanism includes regulating the expression of Bcl-2 family proteins, reducing the anti apoptotic protein Bcl-2, increasing the level of pro apoptotic protein Bax, releasing mitochondrial cytochrome c, activating the caspase cascade reaction, and ultimately inducing programmed cell death. In addition, mountain ginger extract can regulate the expression of XIAP (X-linked inhibitor of apoptosis protein), relieve the inhibition of caspase, and enhance apoptosis signaling.
Multi organ protective effect
The protective effects of mountain ginger extract on the liver, cardiovascular system, lungs, and nervous system are increasingly receiving attention. It reduces organ damage through multiple mechanisms such as antioxidant, anti-inflammatory, and regulation of cell apoptosis. For example, in terms of liver protection, mountain ginger extract can inhibit oxidative stress and inflammatory response of liver cells, and alleviate the process of liver fibrosis. The cardiovascular protective effect is manifested by reducing myocardial ischemia-reperfusion injury, regulating related targets such as APP, PTPN1, MAOA, ABCB1, etc., and improving myocardial cell function. The protective effect of the lungs is mainly achieved by inhibiting inflammation and oxidative damage, reducing chronic obstructive pulmonary disease (COPD) and acute lung injury. In terms of neuroprotection, mountain ginger extract can delay neurodegenerative diseases by regulating neuroinflammation and oxidative stress.
Mechanism of action and molecular targets
The multi-target mechanism of action of mountain ginger extract enables it to exhibit a wide range of pharmacological activities in various disease models. Its main targets and signaling pathways include:
- Bcl-2 family proteins Shanjiangsu, a key protein regulating cell apoptosis, promotes mitochondrial pathway apoptosis by reducing Bcl-2 and increasing Bax expression.
- XIAP Apoptosis inhibitory protein, mountain ginger extract downregulates XIAP, relieves inhibition of caspase, and promotes cell apoptosis.
- PPAR-γNuclear receptor transcription factors regulate inflammation and metabolism, while resveratrol activates PPAR - γ and inhibits inflammatory responses.
- Nrf2 The key transcription factor for antioxidant stress, mountain ginger extract, activates Nrf2 signaling and enhances cellular antioxidant capacity.
- TLR4 The pattern recognition receptor of immune response, Shan Jiang Su, inhibits TLR4 expression and alleviates LPS induced inflammatory response.
- Myocardial infarction related targets Including APP, PTPN1, MAOA, ABCB1, ABCG2, SYNJ2, ALOX5, TRPV1, CNR1, and SHBG, these targets are involved in myocardial cell metabolism, inflammation, oxidative stress, and ion channel regulation. Shanjiangsu exerts myocardial protection by regulating these targets.
In addition, mountain ginger extract also affects various signaling pathways, such as MAPK, NF - κ B, PI3K/Akt, etc., synergistically regulating cell survival, inflammation, and metabolic processes.
Evaluation of drug properties and pharmacokinetics
The pharmacological evaluation of Shanjiangsu shows that it has good potential for drug development. Its molecular weight is moderate (270.28), which conforms to Lipinski's rule. A LogP value of 2.4 indicates that it has suitable lipid solubility, which is conducive to oral absorption and cell membrane penetration. The TPSA is 55.76 and the number of hydrogen bond acceptors is 4, both of which are favorable for bioavailability. The high permeability of the blood-brain barrier suggests its potential application in central nervous system diseases. In terms of safety, mountain ginger extract has no significant liver toxicity, cardiac toxicity, or hERG channel inhibition. Its Ames test is negative, indicating a low risk of mutagenicity.
Pharmacokinetic studies have shown that mountain ginger extract is well absorbed after oral administration, with a moderate plasma half-life and widespread distribution, especially in high concentrations in the heart, liver, and brain tissues. Its metabolism is mainly through the phase I and phase II enzyme systems of the liver, and the metabolites are relatively stable. The main excretion pathways are bile and urine. Currently, there is a lack of systematic preclinical pharmacokinetic data, and further research is needed to improve related studies in the future.
Clinical application prospects and prospects
Shanjiangsu, with its multi-target and multi mechanism pharmacological properties, has shown broad clinical application prospects in the fields of anti-tumor, anti-inflammatory, cardiovascular protection, and neuroprotection. Its regulation of targets related to myocardial infarction provides new ideas for the prevention and treatment of cardiovascular diseases. The anti-inflammatory and antioxidant effects make it potentially valuable in chronic inflammatory diseases and metabolic syndrome. The neuroprotective effect provides the possibility for the treatment of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Future research should focus on:
- Preclinical pharmacokinetic and toxicological evaluation of the system To lay the foundation for clinical trials.
- In depth analysis of its molecular mechanism and target network Using multi omics techniques to reveal the full picture of its effects.
- Structural optimization and formulation development Improve its bioavailability and targeting.
- Clinical trial design Verify its safety and effectiveness, and promote its clinical translation.
- Combination therapy research Explore synergistic effects with existing drugs to enhance treatment efficacy.
Conclusion
As a natural flavonoid compound with multiple biological activities, mountain ginger extract exhibits unique pharmacological advantages in antibacterial, anti-inflammatory, anti-tumor, and multi organ protection. Its good drug efficacy and safety provide a solid foundation for the development of new drugs. In the future, through in-depth mechanism research and clinical translation, mountain ginger extract is expected to become an important candidate drug for treating various complex diseases. With the continuous development of pharmacology of natural products, the research on mountain ginger extract will promote the rational utilization of natural medicinal resources and innovative drug development, contributing new strength to human health.